News Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors Staff September 11, 2023 Iframe sync Post navigation Previous: InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904Next: APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF) More Stories Healthcare News Pharmaceutical Queue Ventures Announces Closing of Brokered Private Placement of Subscription Receipts of Custom Fundco Inc. Staff December 5, 2025 Healthcare News Pharmaceutical Queue Ventures Announces Closing of Brokered Private Placement of Subscription Receipts of Custom Fundco Inc. Staff December 5, 2025 Coronavirus COVID-19 News Patient Care Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement Staff December 5, 2025
